| Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors P Kaptein, C Jacoberger-Foissac, P Dimitriadis, P Voabil, M de Bruijn, ... Science translational medicine 14 (642), eabj9779, 2022 | 29 | 2022 |
| Clinical insignficance of monoclonal T-cell populations and duodenal intraepithelial T-cell phenotypes in celiac and nonceliac patients R Celli, P Hui, H Triscott, S Bogardus, J Gibson, M Hwang, ME Robert The American Journal of Surgical Pathology 43 (2), 151-160, 2019 | 28 | 2019 |
| Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy C Jacoberger-Foissac, SJ Blake, J Liu, E McDonald, H Triscott, ... Journal for ImmunoTherapy of Cancer 8 (2), 2020 | 15 | 2020 |
| Engineering neoantigens to form immunogenic biopolymer particles targeting metastatic breast cancer S Pounraj, S Chen, H Triscott, AK Lam, L Ma, BHA Rehm Applied Materials Today 38, 102238, 2024 | | 2024 |
